Bone Density and Osteoporosis Risk: What Women Need to Know Before Symptoms Appear

Why Osteoporosis Is Called a Silent Disease

Osteoporosis — a condition in which bones lose density and become more prone to fracture — rarely announces itself. There is no pain as bone mass gradually declines, no visible sign, and no warning that a simple fall could cause a serious injury. By the time a fracture occurs, significant bone loss has often already taken place over many years.

This silence is precisely why proactive screening matters. As explained in our guide why screenings are designed to catch problems before warning signs emerge, many serious conditions in women — including bone loss — are detectable long before they cause harm. Understanding the disease process is the first step toward staying ahead of it.

How Bone Density Changes Across a Woman's Life

Bone is living tissue that is constantly being broken down and rebuilt. Peak bone mass — the maximum amount of bone a person accumulates — is typically reached in the late 20s to early 30s. After that, bone remodeling gradually shifts toward more breakdown than formation.

For women, this process accelerates significantly around menopause. The decline in estrogen — a hormone that helps protect bone — triggers a period of accelerated bone loss that can continue for several years after the final menstrual period. According to the National Institutes of Health (NIH), women can lose up to 20% of their bone density in the five to seven years following menopause.

This biological reality means that the foundation for lifelong bone health is built earlier in life than most people assume. Nutrition, physical activity, and other lifestyle choices during adolescence and young adulthood directly influence peak bone mass — and therefore, long-term risk.

Who Should Be Screened and When

The U.S. Preventive Services Task Force (USPSTF) recommends bone density screening for all women aged 65 and older. For women younger than 65, screening may be recommended if their 10-year fracture risk is equal to or greater than that of a 65-year-old white woman with no additional risk factors — a threshold typically assessed using validated tools such as FRAX (Fracture Risk Assessment Tool).

For a full overview of how bone density screening fits into the broader picture of preventive care, see what each routine women's health screening tests for. Screening frequency after an initial scan depends on baseline results and individual risk — a conversation best had with a primary care provider or gynecologist.

Understanding Your DEXA Scan Results

The standard tool for measuring bone mineral density (BMD) is the DEXA scan (dual-energy X-ray absorptiometry). It is a low-radiation imaging test that typically measures bone density at the hip and lumbar spine — two sites most associated with fracture risk.

Results are reported as a T-score, which compares your bone density to that of a healthy young adult at peak bone mass:

• T-score of -1.0 or above: Normal bone density
• T-score between -1.0 and -2.5: Low bone density (osteopenia) — not osteoporosis, but an indicator of increased risk
• T-score of -2.5 or below: Osteoporosis

A Z-score may also be reported, comparing your density to others of the same age and sex — useful for identifying causes of bone loss that are not simply age-related. For a deeper explanation of scan types and result interpretation, our article how DEXA scan results are interpreted covers this in detail.

Key Risk Factors to Discuss With Your Doctor

Bone density loss is influenced by a combination of factors that are not always obvious. When discussing screening or bone health with your provider, consider raising the following:

• Early menopause (before age 45) or surgical removal of the ovaries
• Long-term use of certain medications, including corticosteroids, proton pump inhibitors, and some anticonvulsants
• Low body weight or a history of eating disorders
• Family history of osteoporosis or hip fracture
• Low calcium or vitamin D intake over the course of a lifetime
• Smoking or heavy alcohol use
• Conditions affecting nutrient absorption, such as celiac disease or inflammatory bowel disease

Women who have experienced commonly overlooked screening gaps — such as delayed bone density testing — may have these risk factors without realizing their cumulative impact. A thorough clinical history helps providers determine whether earlier or more frequent screening is warranted.

Proactive Steps That Support Bone Health

While clinical screening identifies where you stand, day-to-day habits shape where you are headed. Evidence-based strategies for supporting bone density across the lifespan include:

• Adequate calcium intake — through food sources such as dairy, fortified plant milks, leafy greens, and almonds
• Sufficient vitamin D — which is essential for calcium absorption; levels are best assessed by a blood test before supplementing
• Weight-bearing and resistance exercise — activities such as walking, jogging, dancing, and strength training stimulate bone formation
• Avoiding smoking and limiting alcohol consumption, both of which are associated with accelerated bone loss
• Fall prevention — for those already at elevated risk, reducing fall hazards in the home and working on balance and strength are practical priorities

For a detailed look at the nutritional side of bone health, how calcium and vitamin D work together to protect bone density explains the evidence clearly. These are modifiable factors — small, consistent choices that compound in their effect over years and decades.

This article is for informational purposes only and does not constitute medical advice. Bone health decisions, including the need for screening or treatment, should be made in consultation with a qualified healthcare provider who can assess your individual health history and risk profile.